GlassScriptPhysician profile
Katty Afshar
NPI 1114365160
$904.94
in general payments reported to CMS, 2019-2025
19 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.81 · 2021: $60.64 · 2022: $149 · 2023: $254 · 2024: $252 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $123.94 | 2021-2024 | Breztri |
| Pfizer INC. | $108.92 | 2019-2024 | |
| Inari Medical, INC. | $106.00 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shionogi INC | $75.48 | 2022-2024 | Fetroja |
| Janssen Pharmaceuticals, INC | $65.18 | 2022-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $57.97 | 2022-2023 | |
| Stryker Corporation | $46.39 | 2025 | Flowtriever |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.70 | 2023-2024 | Jardiance |
| Abbott Laboratories | $44.41 | 2023-2025 | Freestyle Libre 3, Mitraclip |
| Recor Medical INC | $33.53 | 2025 | Paradise Ultrasound Renal Denervation System |
| Abbvie INC. | $28.46 | 2021 | |
| Boston Scientific Corporation | $27.21 | 2024 | Watchman Flx |
| Daiichi Sankyo INC. | $25.90 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.07 | 2025 | Xifaxan |
| Atricure, INC. | $21.99 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $21.86 | 2025 | |
| Gilead Sciences, INC. | $20.06 | 2023 | |
| Bioxcel Therapeutics, INC. | $17.57 | 2023 | Igalmi |
| Melinta Therapeutics, LLC | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katty Afshar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.